481 related articles for article (PubMed ID: 947860)
21. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
Plain MJ; Whitehead RH; Jose DG
Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
[TBL] [Abstract][Full Text] [Related]
22. Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate.
Bhatti RA; Ablin RJ; Condoulis W; Guinan PD
Cancer Res; 1979 Sep; 39(9):3328-31. PubMed ID: 476662
[TBL] [Abstract][Full Text] [Related]
23. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
24. Sensitization to tumour-associated antigens in human breast carcinoma.
Cochran AJ; Grant RM; Spilg WG; Mackie RM; Ross CE; Hoyle DE; Russell JM
Int J Cancer; 1974 Jul; 14(1):19-25. PubMed ID: 4617707
[No Abstract] [Full Text] [Related]
25. Leukocyte migration inhibition by cancer patients' sera.
Cochran AJ; Mackie RM; Ross CE; Ogg LJ; Jackson AM
Int J Cancer; 1976 Sep; 18(3):274-81. PubMed ID: 1066319
[TBL] [Abstract][Full Text] [Related]
26. Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition.
Tanaka F; Sawada K; Yonemoto RH
Gan; 1980 Oct; 71(5):589-95. PubMed ID: 7014342
[TBL] [Abstract][Full Text] [Related]
27. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
Maluish A; Halliday WJ
J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
[No Abstract] [Full Text] [Related]
28. Leukocyte activation in advanced cancer as an explanation for absent leukocyte adherence inhibition to cancer extracts and chemoattractant.
Labateya N; Thomson DM; Reid EC
Eur J Cancer Clin Oncol; 1986 Jan; 22(1):33-43. PubMed ID: 3007156
[TBL] [Abstract][Full Text] [Related]
29. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
Shenouda G; Thomson DM
Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
[TBL] [Abstract][Full Text] [Related]
30. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
Winter M; Nelson DS; Milton GW
Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
[TBL] [Abstract][Full Text] [Related]
31. Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF).
Harding MW; Yang TJ
Cell Immunol; 1984 Aug; 87(1):206-16. PubMed ID: 6204773
[TBL] [Abstract][Full Text] [Related]
32. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
[TBL] [Abstract][Full Text] [Related]
33. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
Shenouda G; Thomson DM; MacFarlane JK
Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
[TBL] [Abstract][Full Text] [Related]
34. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
35. The capillary tube leucocyte migration technique (LMT) as a method for detection of serum inhibiting activity of tumour-directed, cellular hypersensitivity in patients with renal carcinomas.
Kjoer M
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):294-6. PubMed ID: 4528017
[No Abstract] [Full Text] [Related]
36. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
37. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
Müller S; Ernst TM
Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
[TBL] [Abstract][Full Text] [Related]
39. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
40. Role of circulating antibodies in the humoral leukocyte adherence inhibition response of lung and breast cancer patients.
Kotlar HK; Sanner T
Cancer Lett; 1980 Nov; 11(1):11-9. PubMed ID: 7013972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
